Vir Biotechnology, Inc.
VIR· Nasdaq
Released Aug 5, 2021, after the close
10-Q filed Aug 5, 2021, 36 days after period end · 0000950170-21-000935
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $177.07M | $66.99M | $2.05M | $2.22M |
| Net Income | $61.81M | -$31.17M | -$33.93M | -$24.45M |
| EPS Diluted |
Vir Biotechnology, Inc. · CIK 1706431 · Engraved from SEC EDGAR
| $0.46 |
| -$0.27 |
| -$3.64 |
| -$3.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.